2m 2m 2m 2m 2m 2m 2m
BIOFRONTERA (BFRI)
NASDAQ
$1.12+$0.01 (+0.99%)
Price as of Jul 14, 2026 5:03 AM EDT- $14.2MMarket Cap
- 29.07%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOFRONTERA (BFRI)
$1.12+$0.01 (+0.99%)
BFRI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.11 | ||
Change | +$0.01 (+0.91%) | ||
Open | $1.10 | ||
High | $1.16 | ||
Low | $1.09 | ||
Previous Close | $1.10 | ||
Volume | 324,666 | ||
30-Day Average Volume | 407,336 | ||
1-Week Change | -4.31% | ||
1-Month Change | 28.31% | ||
1-Year Change | 29.07% | ||
3-Year Change | -88.50% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $24.8M | ||
Market Cap | $14.2M | ||
Enterprise Value | $12.6M | ||
Period: QTR TTM FY | |||
Revenue | $10.1M | ||
Net Income | N/A | ||
Free Cash Flow | -$75,000.00 | ||
EBIT | $125,000.00 | ||
EBITDA | $180,000.00 | ||
Net Working Capital | $2.2M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | 70 | ||
Enterprise Value/Revenue | 1 | ||
P/B | N/A | ||
P/E | -3 | ||
PEG | N/A | ||
Price/Free Cash Flow | -189 | ||
Price/Operating Cash Flow | -203 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 07/05/2023 | ||
Earnings & Revenue